HealthNews
Medtronic exceeds quarterly expectations on strong demand for heart devices.
Bengaluru, India: Medtronic surpassed Wall Street estimates in the fourth quarter for revenue and adjusted profits. The company rode a wave of constant demand for its heart device used for complex cardiac procedures. Medtronic has focused on smaller and targeted acquisitions in order to enhance its portfolio after its spin-off of its diabetes business. Medtronics growth levers are its pulsed-field ablation systems and transcatheter valve replacement devices. These two minimally-invasive cardiovascular technologies have seen rid adoption. According to LSEG, the revenue for the fourth quarter was $9.81 billion compared to estimates of $9.63billion. The company’s pulsed field ablation segment, which represents nearly 40% of its sales, saw a 13.8% increase in revenue to $3.8 billion for the fourth quarter. Sales in the company’s neuroscience segment increased 5%, to $2.75 Billion. This was slightly less than analysts’ estimates of $2.76 Billion. Medtronic, on an adjusted basis reported a quarterly profit of 1,55 per share. This was just above the average analyst estimate of 1,54 per share. According to LSEG data, the Dublin, Ireland based company projected adjusted annual profits in the range between $5.90 and $6 per share in fiscal 2027. This is below the $6.06 analysts penciled in. Medtronic reported last quarter it expects to incur a tariff hit of about $300 million in fiscal year 2027. That’s up from roughly $185 million the previous fiscal year. (Reporting and editing by Padmanabhan Ananthan in Bengaluru, Christy Santhosh)
Published on Jun 6, 2026, at 7:31 AM (IST)
Join a community of more than 2 million industry professionals. Subscribe to our Newsletter for the latest industry insights and analysis.
You can now get all the information about ETHealthworld on your mobile!
HealthNews
Manipal Health leases a hospital in Bengaluru for a long time.
Temasek-backed Manipal Health Enterprises, a hospital chain operated by Temasek-backed TPG, has leased a multi-speciality building of 2.45 lakh square feet in Bengaluru’s Yelahanka district. The total rental cost is estimated to be around Rs 816.12 cr over the lease term after factoring scheduled rent increases. The property consists of three basement floors, a first floor and ten upper floors. Manipal Health Enterprises is paying a monthly rent starting at Rs 1,27 crore. This translates into Rs 52 per square foot per month. In connection with the transaction, Manipal Health Enterprises has paid a security of Rs 7.64 billion. In January 2010, the company bought a hospital building in Mumbai’s west suburb Andheri, for Rs. 495 crore. This was one of India’s largest healthcare real-estate transactions of the year. This multi-specialty building, built by JKC Varma & Other in Venkatala near Yelahanka was leased to the healthcare operator under a new lease agreement, for a duration of 29 years and eleven months. These documents were accessed via Propstack, a data platform that analyzes realty. The lease agreement stipulates a 10% rent increase in the sixth-year. Rents will then increase by 15 percent every three years until the end of the lease, which would result in a significant rental increase over the next three decades.
Based upon the initial rent, and the agreed-upon escalation scheme, the total rental expenditure over the 29 years and 11 months lease term comes to about Rs 816.12 Crore. Manipal Health Enterprises is expanding in major Indian cities by acquiring brownfield sites and expanding existing facilities. The ET’s email to Manipal Health Enterprises was not answered until the time of publication. The transaction demonstrates the preference for long-term occupancy by healthcare operators in urban markets. Bengaluru is still experiencing strong demand in the office, residential and healthcare real estate segments. This is due to sustained population and economic growth.
The large-format assets of hospitals are usually leased for a long time due to the substantial investments in medical equipment, fit outs and operational infrastructure. These agreements provide tenants with long-term security and stability in business, while also ensuring a stable rental income for the property owner. The expansion of hospital networks in India, the rise in healthcare demand, and the need for long-term occupancy are driving this sector to grow at a rid rate.
Because hospitals require substantial investments in equipment and fittings, long-term leases are essential for stability. These large-scale transactions also show the convergence between healthcare and realty, as operators are increasingly securing strategic assets in key cities to support their future expansion.
Published on Jun 5, 2026, at 7:46 AM (IST)
Join our community of over 2 million industry professionals. Subscribe to our Newsletter for the latest industry insights & analyses.
You can now get all the information about ETHealthworld on your mobile!
HealthNews
Paras Healthcare files preliminary documents with Sebi in order to raise Rs 1,800 Crore through an Initial Public Offering (IPO)
New Delhi, Paras Healthcare Ltd. which operates hospitals under “Paras Health” brand has filed preliminary perwork with cital market regulator Sebi. Dharminder Kumar Nagar, the promoter of Paras Healthcare Ltd and other investors are selling shares. The Gurugram based company plans to use proceeds from this fresh issue as a prepayment of or repayment of some outstanding borrowings. They will also be investing in their wholly-owned PMHPL subsidiary for debt payments and other corporate purposes. Paras Healthcare, a clinical-specialty-led hospital platform that provides tertiary or quaternary care through an eight-hospital network with a combined cacity of 2,211 bed as of March 31 2026, is a clinically specialty led hospital platform. The company is active in five states and a union territory including Haryana and Bihar. In fiscal 2026, the companys revenue from operation was Rs 1,605.95 billion, while its EBITDA profit (operating income) was Rs 335.58 crore. Paras Healthcare submitted draft IPO pers to Sebi back in 2024, and obtained regulatory proval. However, the company decided not to proceed with its public offering. The book-running lead manager for the issue is JM Financial. BofA Securities India, and Nuvama wealth management are also involved. The proposed listing on BSE and NSE of equity shares. PTI
Published on Jun 5, 2020 at 1:54 PM IST
Join our community of over 2M+ professionals in the industry. Subscribe to our Newsletter for the latest industry insights and analysis.
Your smartphone is your portal to ETHealthworld!
HealthNews
Warburg, KKR and TPG are among the PE giants competing for a 25% stake of Cloudnine.
Mumbai – Global private equity firms Warburg Pincus and KKR as well as TPG Cital and Advent International along with CVC Cital Partners and Permira and homegrown Kedaara Cital have entered the race to buy a 25% stake of Cloudnine – India’s largest maternity hospital and pediatric chain. The people who spoke to us said that the proposed deal would value Cloudnine around Rs10,000 crore ($1billion). Allegro Cital will be running the sales process, with initial bids due by the first week of July. True North, a current investor in the deal, will exit completely. According to the above-mentioned people, Temasek and TPG Newquest will likely retain their stakes.
Temasek, TPG Newquest and Cloudnine collectively hold about 52%. About 10% of Cloudnine is owned by the promoter group, and the rest are employee stock options plans (ESOPs). Cloudnine’s plans for raising $200-300m at a valuation $1 billion were first reported by ET on May 10th. True North entered Cloudnine with a Rs400-crore investment in 2015. Matrix Partners, Sequoia Cital and others have invested in Cloudnine before.
Permira, KKR and their spokespeople declined to comment. True North, Warburg Pincus Kedaara Cital CVC TPG Cital and Advent did not respond to emails. Cloudnine is a Bengaluru based company founded in 2006 by Dr R Kishore Kumar and his co-founders Rohit M.A. M. Ramachandra & Vidy Kumar. People said that the company had a revenue of 2,000 crores and Ebitda at 300 crores in FY26.
Published on Jun 4, 2026 10:57 AM (IST)
Join our community of over 2M+ professionals in the industry. Subscribe to our Newsletter for the latest industry insights and analysis.
You can now get all the information about ETHealthworld on your mobile!
HealthNews
Apple’s India health push expands with sleep apnea and hearing tests at home
ple rolled out on Tuesday two major features that are focused on health for Indian users. The company has added sleep nea notification to ple Watch, and validated clinical hearing tests to AirPods Pro 3 to further its push towards preventive healthcare via consumer devices. The new features are designed to help users diagnose health conditions which often go undiagnosed over many years. Sleep nea – a condition in which breathing repeatedly stops while sleeping – is thought to affect over one billion people around the world. It has been linked to heart disease, hypertension and type 2 diabetes. ple Watch’s “Breathing disturbances” feature tracks small wrist movements that occur when breathing patterns are interrupted during sleep. The watch analyzes the data every 30 day and alerts its users if they detect consistent signs of mild to severe sleep disorders.
Users are able to export a PDF report that contains breathing disturbance data for three months. This allows them to share the results with doctors. ple says the feature was created using machine learning, and validated by clinical-grade data on sleep nea. Wearables are moving deeper into healthcare.
ple’s vice-president of Health and Fitness Sumbul Desai said, “We believe that technology should empower people so they can take control of their own health.” ple has introduced a hearing test at home for AirPods Pro owners in India, along with sleep . It uses a standard audiometric method called pure-tone to measure hearing levels. Users can do this in about five minutes by using ple devices compatible with the feature. After the test is completed, users will receive an audiogram, a summary of hearing loss in each ear and recommendations. The results can be stored in the Health p and shared with healthcare providers.
Published on Jun 4, 2026, at 04:56 AM (IST)
Join our community and join 2M+ other industry professionals. Subscribe to our Newsletter for the latest industry insights and analysis.
You can now get all the information about ETHealthworld on your mobile!
HealthNews
KGMU will file FIRs against 4 employees for Rs 2.5 crore of medicine procurement irregularities.
Lucknow – King George’s Medical University, (KGMU), will file an FIR after a probe revealed alleged irregularities in the procurement of medicines under the Asadhya Yojana. The program provides free treatment for chronically ill patients who are poor. The five-member committee investigated irregularities at the Urology Department and recommended that one pharmacist, and three contract employees be punished.
KGMU spokeswoman Prof KK Singh confirmed that the FIR would be filed on February 10. The matter was discovered after officials noted a dramatic increase in the amount of money spent on medicines. From Rs 10 lakhs a month, to Rs 40 Lakhs in February, and Rs 45 Lakhs in March. An audit revealed discrepancies. KGMU halted payment for medicines under investigation and set up a committee, on the orders of vice-chancellor Professor Soniya Nityanand.
This panel reviewed patient records, distribution logs, and payment data. The panel discovered that drugs were being consumed above the recommended dosage.
A drug that was meant to be administered every six months, but instead showed up as being administered four or five times a month in several cases. Each injection costs between Rs 8 000 and Rs 10 000.
The report also revealed cases in which medicines were administered to patients without their consent. It raised suspicions that govt money was being misused.
The investigation highlighted violations of drug management protocols. A contractual employee was responsible for ordering and receiving medicines in violation of the rule which requires that this be done by authorised nursing personnel.
This committee believes that the medicines were diverted. They are investigating where they were disposed. The panel recommended criminal prosecution against the four staff members.
Published on Jun 2, 2026, at 01:02 PM (IST)
Join our community of over 2M+ professionals in the industry. Subscribe to our Newsletter for the latest industry insights & analyses.
You can now get all the information about ETHealthworld on your mobile!
-
LifestyleNews2 weeks agoSpine surgeon rates sofas for your back: Beanbags score 0, lumbar support gets 10
-
UsaLocalNews2 weeks agoDOJ says it scrubbed news releases about Jan. 6 criminal cases from its website
-
Tech2 weeks agoToday's NYT Connections Hints, Answers and Help for May 25, #1079
-
Tech2 weeks agoSennheisers Momentum 5 headphones are all about the audio and ANC upgrades – Engadget
-
Video2 weeks agoThe Odds: Are Americans concerned about AI replacing jobs?
-
Video2 weeks ago911 call reveals more about Kyle Busch’s condition before his sudden death
-
Video2 weeks agoEbola: Everything you need to know about the outbreak | The Global Story
-
Video2 weeks agoShould Disneyland visitors worry about toxic leak?
